Ocugen, Inc.
OCGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $218 | $140 | $279 | $887 |
| - Cash | $59 | $39 | $78 | $95 |
| + Debt | $33 | $7 | $6 | $3 |
| Enterprise Value | $192 | $108 | $208 | $796 |
| Revenue | $4 | $6 | $2 | $0 |
| % Growth | -32.8% | 142.6% | – | – |
| Gross Profit | $2 | $5 | $2 | $0 |
| % Margin | 51.5% | 88.3% | 100% | – |
| EBITDA | -$53 | -$65 | -$89 | -$58 |
| % Margin | -1,301.8% | -1,074% | -3,560.7% | – |
| Net Income | -$54 | -$63 | -$87 | -$58 |
| % Margin | -1,333% | -1,045% | -3,488.9% | – |
| EPS Diluted | -0.2 | -0.26 | -0.4 | -0.3 |
| % Growth | 23.1% | 35% | -33.3% | – |
| Operating Cash Flow | -$42 | -$62 | -$60 | -$48 |
| Capital Expenditures | -$3 | -$10 | -$4 | -$1 |
| Free Cash Flow | -$46 | -$73 | -$65 | -$49 |